6 months of age. Sixty-five production units (sheep and/or goats owned by 1 person or family) were selected from the 6 parishes of Grenada and 9 production units were selected from Carriacou. Of a total of 74 production units, 38 were sheep only, 20 were goat only, and 16 were mixed sheep and goat units. Production units ranged in size from 1 to 150 adult animals. For production units with more than 10 animals, 50% of the animals were sampled. All animals were sampled if the production units consisted of fewer than 10 animals.
A commercially available absorbed ELISA for Map antibodies a reported by the manufacturer to be effective in sheep and goats and evaluated previously 6 was used and interpreted according to manufacturer's instructions based on a sampleto-positive ratio with a positive cutoff of 70. The ELISApositive samples were also tested by agar gel immunodiffusion (AGID) using a commercial test kit b as per the manufacturer's instructions. Fecal smears from ELISA-positive animals were stained and examined microscopically for acid-fast organisms consistent with Map.
Two clinically normal ewes, from different production units on Carriacou, which were each ELISA, AGID, and fecal smear positive, were euthanized and necropsied. From each, the ileocecal area and adjacent ileocecal lymph nodes were collected and divided; 1 portion was fixed in 10% buffered formalin for routine histology and acid-fast staining of sections while the other portion was retained for culture at -80°C, each tissue in a separate sterile container. In addition, portions of ileocecal lymph nodes were also retained at -80°C for direct polymerase chain reaction (PCR). The culture media employed were modified Middlebrook 7H10 agar slants c (medium A), a commercial radiometric liquid medium d (medium B), and a commercial nonradiometric liquid medium e (medium C) following recommendations and formulae as previously described. 15 For media A and B, the 4 tissue samples from each animal were prepared as follows: approximately 1-cm square piece of tissue was minced with sterile scissors, placed in a sterile bag f with phosphate buffered saline and homogenized in a stomacher g for 2 min on the highest setting. The bag's contents were then transferred to a 50-ml conical tube containing 30 ml of sterile water and mixed on a rotary shaker at 1 × g for 30 min. Samples were then held stationary for 30 min at room temperature for particulate matter to settle. The top 20 ml was then transferred to another 50-ml conical tube and centrifuged at 2,000 × g for 20 min in a benchtop centrifuge. h The supernatant was removed, and the pellet was resuspended by vortexing in 0.75% hexadecylpyridinium chloride (HPC). i This HPCtissue mixture was held at room temperature for 3 hr after which it was centrifuged at 2,700 × g for 20 min. The pellet was resuspended by vortexing in 1 ml of an antibiotic cocktail comprised of 10 mg of vancomycin, 5 mg of amphotericin B, and 10 mg of nalidixic acid. After an 18-hr incubation at 37°C, the mixture was used to inoculate media A (100 µl/ slant) and B (500 µl/bottle), and then incubated at 35-37°C for up to 16 weeks, with the latter read weekly on a commercial instrument j as previously described. 3 Residual decontaminated tissue preparations for media A and B were retained at -80°C. For medium C, tissues were prepared according to the manufacturer's instructions, e and medium C was inoculated with 100 µl of tissue preparation, and incubated with hourly monitoring over 49 days. Direct PCR on ileocecal lymph nodes was undertaken using 0.5 g of tissue that was homogenized as per the instructions given by the manufacturer of a commercial kit, k and subjected to DNA extraction using the same commercial kit. k The direct PCR was a commercial real-time PCR l targeting the hspX gene 4 and performed as per manufacturer's instructions.
A 5-target multiplex PCR was used to test DNA extracted from culture-positive samples as previously described. 14 The 5 possible targets were a 16S ribosomal RNA gene target common to all mycobacteria, a chromosomal DNA target (DT1) found in Mycobacterium intracellulare, Mycobacterium avium subsp. sylvaticum, and 2 serotypes of Mycobacterium avium subsp. avium, and 3 mycobacterial insertion sequences (IS1311, IS901, and IS900) that allow identification of Map and discrimination among other members of the M. avium complex. To characterize a specific Map strain, IS1311 amplicons were subjected to HinfI m restriction digestion, and the products of the amplification were visualized and interpreted as previously described 14 after electrophoresis in ethidium bromide-stained gels (Fig. 1) .
The ELISA-positive animals came from 2 parishes of Grenada (St. Andrew and St. David) and 1 from Carriacou parish ( Table 1) . Of the 479 sheep tested, 11 were ELISA positive (5 males and 6 females). Only 1 out of 260 goats was ELISA positive (a doe). Six of the 12 ELISA-positive animals also tested positive by AGID. Four of these 6 showed scant numbers of acid-fast organisms on fecal smears; the remaining 8 ELISA positives were smear-negative.
At necropsy of 2 ELISA-, AGID-, and fecal smearpositive sheep from Carriacou, gross and microscopic findings were consistent with paratuberculosis, with portions of the small intestines from both animals revealing mild thickening, corrugation, and edema, especially at the ileocecal junction. Mesenteric ileocecal lymph nodes were enlarged, edematous, and hemorrhagic with a few microgranulomatous lesions. Histological studies of these tissues showed significant lymphocytic infiltration plus multiple diffuse chronic granulomatous inflammatory foci and noncapsulated granulomas with epithelioid macrophages and a few Langhans giant cells. Ileocecal sections and adjacent mesenteric lymph nodes revealed acid-fast organisms located within a few macrophages.
Direct PCR on ileocecal lymph nodes from both sheep were negative. On culture, modified 7H10 agar slants produced colonies resembling Map from all 4 tissues (2 tissues from each case) within 8 weeks of incubation. All 4 cultures in medium B signaled positive after 5 weeks of incubation. None of the cultures in medium C signaled positive by the end of the standard incubation period (49 days). Aliquots from medium B cultures were acid-fast, and 16S rRNA, DT1, and IS900 positive by multiplex PCR. At a later date, when the ability to genotype the isolates using methods outlined previously 5 became available, the frozen tissue preparation was thawed and incubated in medium B as described above until signaling positive (within a month). These were subcultured onto modified 7H10 (medium A) plates to produce sufficient mycobacterial growth for specific Map strain identification. Pure colonies appeared within 3 months. Restriction enzyme analysis of Map from these colonies demonstrated that both sheep had been infected by a C-type strain of Map.
The surveillance study indicated that Map infection is present in Grenada's small ruminant industry. The current prevalence appears to be low, with a 1.6% animal-level Map seroprevalence in small ruminants from Grenada and Carriacou. The infection also appeared localized in 2 out of 6 Grenada parishes. The true prevalence may be higher because the diagnostic sensitivity of ELISA is low in clinically normal, relatively young ruminants as were tested in the current study (30% of animals were 1.0-1.6 years old). Although only type C strain was isolated from sheep in the present study, in Europe, S strains have been more common in sheep. 13 The prevalence rates reported in small ruminants in some other countries is daunting: 73.7% in sheep in Italy, 1 46.7% in sheep in Portugal, 2 52% in sheep and 50% in goats in Cyprus, 8 48-57% in goats and 42.4% in sheep in Brazil. 10 In infected sheep flocks with S strains, animals can shed very high numbers of organisms, leading to a very high degree of environmental contamination. The low seroprevalence of Map in clinically normal animals on the islands of Grenada and Carriacou suggest that prompt steps taken to prevent spread of infection are likely to be successful. The current study from the Caribbean region may provide a baseline for annual screening of this disease using ELISA. 
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